Dacarbazine-d6 – 1 mg

Brand:
Cayman
CAS:
1185241-28-4
Storage:
-20
UN-No:
Non-Hazardous - /

Dacarbazine-d6 is intended for use as an internal standard for the quantification of dacarbazine (Item No. 21877) by GC- or LC-MS. Dacarbazine is a DNA alkylating prodrug that is activated by P450 enzymes in liver microsomes.{21297} Following activation, it is converted, through a series of reactions, into a methyldiazonium cation that alkylates DNA at all phases of the cell cycle and induces apoptosis. In vitro, dacarbazine inhibits the growth of B16/F1, A-875, and SK-MEL-5 melanoma and non-cancerous WI-38 lung fibroblast and L-02 hepatocyte cell lines (IC50s = 260, 287, 380, 526, and 367 μM, respectively).{41584} Dacarbazine toxicity to 518A2 and SK-MEL-28 melanoma cell lines increases in a time-dependent manner with IC50 values of 121 and >400 μM, respectively, following a 1 hour incubation and 2.5 and 50 μM, respectively, following a 96 hour incubation.{41585} In vivo, dacarbazine (70 mg/kg, once every 2 days) decreases tumor volume by 59.1% in a B16/F1 murine melanoma model in mice.{41584} Formulations containing dacarbazine have been used in the treatment of metastatic melanoma and for Hodgkin’s lymphoma in combination with other antineoplastic agents.  

 

Available on backorder

SKU: 30771 - 1 mg Category:

Description

An internal standard for the quantification of dacarbazine by GC- or LC-MS


Formal name: 5-(3,3-dimethyl-1-triazen-1-yl)-1H-imidazole-4-d6-carboxamide

Synonyms: 

Molecular weight: 188.2

CAS: 1185241-28-4

Purity: ≥99% deuterated forms (d1-d6)

Formulation: A solid